SEC Form D · filed June 28, 2017
Syntimmune, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Richard Blumberg, M.D · NEW YORK, NYDirectorLaurence Blumberg, M.D · NEW YORK, NYExec · DirectorSeth Harrison, M.D · NEW YORK, NYDirectorPaul Nardone · Atlanta, GAExec · DirectorJoel Shapiro · Atlanta, GADirectorDavid De Graaf, Ph.D · NEW YORK, NYExec · DirectorSam Hall, Ph.D · NEW YORK, NYDirectorBurt Adelman, M.D · NEW YORK, NYDirectorAaron Kantoff · NEW YORK, NYDirectorHarvey A. Bookstein · Los ANgeles, CADirectorJeffrey R. Bruce · Concord, MAExec · DirectorSeth Harrison, M.D · NEW YORK, NYDirectorDavid De Graaf, Ph.D · NEW YORK, NYExec · DirectorSam Hall, Ph.D · NEW YORK, NYDirectorBurt Adelman, M.D · NEW YORK, NYDirectorAaron Kantoff · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗